Napier Park Global Capital (US)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-29,512
Closed -$1.21M 19
2019
Q2
$1.21M Buy
+29,512
New +$1.17M 1.5% 6

Other funds holding PFE

Napier Park Global Capital (US)'s PFE Position: Q3 2019 in Review

Napier Park Global Capital (US) sold out of Pfizer (PFE) in Q3 2019, closing a stake of 29,512 shares — an estimated $1.21M sold.

Napier Park Global Capital (US) first reported a position in PFE in Q2 2019 and held it in 1 quarter. The position peaked at $1.21M in Q2 2019. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Napier Park Global Capital (US) reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
  • Napier Park Global Capital (US) sold 29,512 Pfizer shares in Q3 2019, an estimated $1.21M.
  • Napier Park Global Capital (US) first reported a position in Pfizer in Q2 2019 and held it in 1 quarter.
  • Napier Park Global Capital (US)'s Pfizer position peaked at $1.21M in Q2 2019.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Napier Park Global Capital (US)'s 13F filing for Q3 2019, filed 13 Nov 2019.